A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells

Hilal S. Khalil, Simon P. Langdon, Alexey Goltsov, Tero Soininen, David J. Harrison, James Bown, Yusuf Y. Deeni

    Research output: Contribution to journalArticle

    13 Citations (Scopus)
    47 Downloads (Pure)

    Profiles

    James Bown

    Person: Academic